Harpoon Therapeutics Inc (HARP) Insider Trading
- $511,888,970.44
- $45,485,672.23
- March 11, 2024
- Ansbert Gadicke
Trader Name | Date | Title | Amount | Price | Type | Total Value |
---|---|---|---|---|---|---|
March 11, 2024 | Major Shareholder | 21,397,205 | $23.00 | Buy | $492,135,715.00 | |
March 23, 2023 | Director | 10,000 | $1,000.00 | Buy | $10,000,000.00 | |
Sept. 22, 2021 | CFO | 10,300 | $8.10 | Buy | $83,430.00 | |
July 1, 2021 | Insider | 10,000 | $14.00 | Sell | $140,000.00 | |
June 1, 2021 | Major Shareholder | 18,491 | $20.44 | Sell | $377,956.04 | |
May 28, 2021 | Major Shareholder | 13,885 | $21.12 | Sell | $293,251.20 | |
May 26, 2021 | Major Shareholder | 3,198 | $20.04 | Sell | $64,087.92 | |
May 24, 2021 | Major Shareholder | 5,000 | $20.12 | Sell | $100,600.00 | |
May 21, 2021 | Major Shareholder | 10,907 | $20.21 | Sell | $220,430.47 | |
May 19, 2021 | Major Shareholder | 17,833 | $20.39 | Sell | $363,614.87 | |
May 17, 2021 | Major Shareholder | 4,666 | $20.07 | Sell | $93,646.62 | |
May 14, 2021 | Major Shareholder | 6,900 | $20.04 | Sell | $138,276.00 | |
May 12, 2021 | Major Shareholder | 29,684 | $20.53 | Sell | $609,412.52 | |
May 10, 2021 | Major Shareholder | 17,133 | $21.80 | Sell | $373,499.40 | |
May 4, 2021 | Major Shareholder | 328,519 | $22.48 | Sell | $7,385,107.12 | |
April 29, 2021 | Major Shareholder | 130,143 | $21.99 | Sell | $2,861,844.57 | |
April 21, 2021 | Major Shareholder | 8,972 | $18.97 | Sell | $170,198.84 | |
April 19, 2021 | Major Shareholder | 10,056 | $19.30 | Sell | $194,080.80 | |
April 16, 2021 | Major Shareholder | 5,847 | $19.86 | Sell | $116,121.42 | |
April 14, 2021 | Major Shareholder | 1,671 | $20.77 | Sell | $34,706.67 | |
April 12, 2021 | Major Shareholder | 20,628 | $21.02 | Sell | $433,600.56 | |
April 9, 2021 | Major Shareholder | 10,300 | $23.67 | Sell | $243,801.00 | |
April 1, 2021 | Insider | 10,000 | $20.45 | Sell | $204,500.00 | |
Feb. 10, 2021 | Major Shareholder | 183,051 | $20.00 | Sell | $3,661,020.00 | |
Feb. 8, 2021 | Major Shareholder | 72,128 | $20.04 | Sell | $1,445,445.12 | |
Feb. 4, 2021 | Major Shareholder | 29,730 | $20.37 | Sell | $605,600.10 | |
Feb. 2, 2021 | Major Shareholder | 48,421 | $20.13 | Sell | $974,714.73 | |
Jan. 27, 2021 | Major Shareholder | 706,825 | $20.00 | Sell | $14,136,500.00 | |
Jan. 25, 2021 | Major Shareholder | 13,006 | $21.23 | Sell | $276,117.38 | |
Jan. 22, 2021 | Major Shareholder | 24,695 | $21.72 | Sell | $536,375.40 | |
Jan. 20, 2021 | Major Shareholder | 17,694 | $24.04 | Sell | $425,363.76 | |
Jan. 4, 2021 | Insider | 10,000 | $18.38 | Sell | $183,800.00 | |
Aug. 18, 2020 | CFO | 2,098 | $11.60 | Buy | $24,336.80 | |
July 31, 2020 | CFO | 1,817 | $10.92 | Buy | $19,841.64 | |
July 1, 2020 | Insider | 10,000 | $16.20 | Sell | $162,000.00 | |
May 27, 2020 | Major Shareholder | 12,064 | $22.39 | Sell | $270,112.96 | |
May 18, 2020 | Insider | 1,522 | $14.77 | Sell | $22,479.94 | |
May 11, 2020 | Insider | 1,000 | $14.07 | Sell | $14,070.00 | |
May 8, 2020 | Insider | 1,000 | $14.00 | Sell | $14,000.00 | |
May 1, 2020 | Insider | 5,826 | $12.07 | Sell | $70,319.82 | |
April 28, 2020 | Insider | 1,250 | $14.05 | Sell | $17,562.50 | |
April 17, 2020 | Insider | 1,021 | $12.08 | Sell | $12,333.68 | |
April 13, 2020 | Insider | 4,556 | $12.06 | Sell | $54,945.36 | |
April 6, 2020 | Insider | 700 | $12.00 | Sell | $8,400.00 | |
March 2, 2020 | Insider | 5,826 | $14.68 | Sell | $85,525.68 | |
Feb. 3, 2020 | Insider | 5,826 | $13.90 | Sell | $80,981.40 | |
Jan. 21, 2020 | CFO | 6,700 | $14.09 | Buy | $94,403.00 | |
Jan. 16, 2020 | Insider | 1,521 | $14.94 | Sell | $22,723.74 | |
Jan. 2, 2020 | Insider | 10,000 | $14.40 | Sell | $144,000.00 | |
Dec. 27, 2019 | Director | 87,379 | $15.98 | Sell | $1,396,316.42 |
Insiders are both buying and selling Harpoon Therapeutics Inc stock.
The insider traders at Harpoon Therapeutics Inc are: Ansbert Gadicke, Natalie Sacks, Bioventures 2014 L.P. Mpm, Holger Wesche, Bioscience Plc Arix, Georgia Erbez, Gerald Phd Mcmahon, Mark Chin, Impact Fund (Cayman) Oncology, Merck & Co., Inc., Luke Evnin, Patrick Baeuerle, and Ronald Hunt
The most active insider trader at Harpoon Therapeutics Inc is Ansbert Gadicke with 15 trades.
Bioventures 2014 L.P. Mpm has sold the most Harpoon Therapeutics Inc stock with a total value of $22,130,549.83.
Merck & Co., Inc. has bought the most Harpoon Therapeutics Inc stock with a total value of $984,271,430.00.
The most recent insider trade for Harpoon Therapeutics Inc was on March 11, 2024.
The single biggest insider buy for Harpoon Therapeutics Inc was from Merck & Co., Inc. with a total value of $492,135,715.00 on March 11, 2024.
The single biggest insider sell for Harpoon Therapeutics Inc was from Bioventures 2014 L.P. Mpm with a total value of $14,136,500.00 on Jan. 27, 2021.